Global and China Recombinant Human Coagulation VIIa Market Status and Forecast 2022-2028

Global and China Recombinant Human Coagulation VIIa Market Status and Forecast 2022-2028

Market Analysis and Insights: Global Recombinant Human Coagulation VIIa and China Market
Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028.
China Recombinant Human Coagulation VIIa market size was US$ 29.1 million in 2021, while the North America was US$ 507.26 million. The proportion of the China was 2.57% in 2021, while North America percentage was 44.74%.
The global major manufacturers of Recombinant Human Coagulation VIIa include Novo Nordisk, GENERIUM , LFB SA HEMA Biologics, AryoGen Pharmed, etc. In terms of revenue, the global three largest players hold a 99.16% market share of Recombinant Human Coagulation VIIa in 2021.
Global Recombinant Human Coagulation VIIa Scope and Market Size
Recombinant Human Coagulation VIIa market is segmented by region (country), by players, by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Human Coagulation VIIa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

For China market, this report focuses on the Recombinant Human Coagulation VIIa market size by players, by Type, and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in China.

The Key manufacturers that are operating in the global Recombinant Human Coagulation VIIa market are:
Novo Nordisk
GENERIUM
LFB SA HEMA Biologics
AryoGen Pharmed

Segment by Type
Vial
Prefilled Syringe

Segment by Application
Congenital Hemophilia
Acquired Hemophilia
Other

Segment by Region
North America
Europe
Japan & Korea
China
India
Latin America


1 Market Overview
1.1 Recombinant Human Coagulation Viia Product Introduction And Study Scope
1.2 Market By Type
1.2.1 Global Recombinant Human Coagulation Viia Market Size Growth Rate By Type
1.2.2 Vial
1.2.3 Prefilled Syringe
1.3 Market By Application
1.3.1 Global Recombinant Human Coagulation Viia Market Size Growth Rate By Application
1.3.2 Congenital Hemophilia
1.3.3 Acquired Hemophilia
1.4 Recombinant Human Coagulation Viia Industry Background, History, Status And Forecast
1.4.1 Recombinant Human Coagulation Viia Industry Status
1.4.2 Recombinant Human Coagulation Viia Industry Trends
2 Global Recombinant Human Coagulation Viia Market Size
2.1 Global Recombinant Human Coagulation Viia Supply And Demand, (2017-2028)
2.1.1 Global Recombinant Human Coagulation Viia Capacity, Production, Capacity Utilization, Status And Forecast, 2017-2028
2.1.2 Global Recombinant Human Coagulation Viia Production By Region: 2017-2022
2.2 Global Recombinant Human Coagulation Viia Sales And Revenue
2.2.1 Global Recombinant Human Coagulation Viia Revenue, (2017-2028)
2.2.2 Global Recombinant Human Coagulation Viia Sales, 2017-2028
2.2.3 Global Recombinant Human Coagulation Viia Price, 2017-2028
3 Competition By Manufacturers
3.1 Global Recombinant Human Coagulation Viia Sales By Manufacturers
3.1.1 Global Recombinant Human Coagulation Viia Sales By Manufacturer (2017-2022)
3.1.2 Global Recombinant Human Coagulation Viia Revenue By Manufacturer (2017-2022)
3.1.3 Global Manufacturers Ranked By Recombinant Human Coagulation Viia Revenue
3.1.4 Global Recombinant Human Coagulation Viia Sales Price By Manufacturers
3.2 China Recombinant Human Coagulation Viia Sales By Manufacturer
3.2.1 China Recombinant Human Coagulation Viia Sales By Manufacturer (2017-2022)
3.2.2 China Recombinant Human Coagulation Viia Revenue By Manufacturer (2017-2022)
3.2.3 China Manufacturers Ranked By Recombinant Human Coagulation Viia Revenue
3.2.4 China Recombinant Human Coagulation Viia Sales Price By Manufacturers
3.3 Recombinant Human Coagulation Viia Manufacturing Base Distribution And Headquarters
3.4 Manufacturers Recombinant Human Coagulation Viia Product Offered
3.5 Analysis Of Competitive Landscape
3.5.1 Global Top 3 Companies By Recombinant Human Coagulation Viia Revenue In 2021
3.5.2 Global Recombinant Human Coagulation Viia Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
3.6 Mergers & Acquisitions, Expansion Plans
4 Global Recombinant Human Coagulation Viia Analysis By Region
4.1 Global Recombinant Human Coagulation Viia Revenue By Region: 2017 Vs 2021 Vs 2028
4.1.1 Global Top Recombinant Human Coagulation Viia Regions By Revenue
4.1.2 Global Top Recombinant Human Coagulation Viia Regions By Revenue (2023-2028)
4.2 Global Top Recombinant Human Coagulation Viia Regions By Sales: 2017 Vs 2021 Vs 2028
4.2.1 Global Top Recombinant Human Coagulation Viia Regions By Sales (2017-2022)
4.2.2 Global Top Recombinant Human Coagulation Viia Regions By Sales (2023-2028)
4.3 North America Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
4.4 Europe Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
4.5 China Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
4.6 Japan & Korea Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
4.7 Latin America Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
4.8 India Recombinant Human Coagulation Viia Sales & Revenue (2017-2028)
5 Corporate Profile
5.1 Novo Nordisk
5.1.1 Novo Nordisk Corporation Information
5.1.2 Novo Nordisk Overview
5.1.3 Novo Nordisk Recombinant Human Coagulation Viia Sales, Price, Revenue And Gross Margin (2017-2022)
5.1.4 Novo Nordisk Recombinant Human Coagulation Viia Product Description
5.1.5 Novo Nordisk Recent Developments
5.2 Lfb Sa Hema Biologics
5.2.1 Lfb Sa Hema Biologics Corporation Information
5.2.2 Lfb Sa Hema Biologics Overview
5.2.3 Lfb Sa Hema Biologics Recombinant Human Coagulation Viia Sales, Price, Revenue And Gross Margin (2017-2022)
5.2.4 Lfb Sa Hema Biologics Recombinant Human Coagulation Viia Product Description
5.2.5 Lfb Sa Hema Biologics Recent Developments
5.3 Aryogen Pharmed
5.3.1 Aryogen Pharmed Corporation Information
5.3.2 Aryogen Pharmed Overview
5.3.3 Aryogen Pharmed Recombinant Human Coagulation Viia Sales, Price, Revenue And Gross Margin (2017-2022)
5.3.4 Aryogen Pharmed Recombinant Human Coagulation Viia Product Description
5.4 Generium
5.4.1 Generium Corporation Information
5.4.2 Generium Overview
5.4.3 Generium Recombinant Human Coagulation Viia Sales, Price, Revenue And Gross Margin (2017-2022)
5.4.4 Generium Recombinant Human Coagulation Viia Product Description
6 Market Size By Type
6.1 Global Recombinant Human Coagulation Viia Sales By Type
6.1.1 Global Recombinant Human Coagulation Viia Historical Sales By Type (2017-2022)
6.1.2 Global Recombinant Human Coagulation Viia Forecasted Sales By Type (2023-2028)
6.1.3 Global Recombinant Human Coagulation Viia Sales Market Share By Type (2017-2028)
6.2 Global Recombinant Human Coagulation Viia Revenue By Type
6.2.1 Global Recombinant Human Coagulation Viia Historical Revenue By Type (2017-2022)
6.2.2 Global Recombinant Human Coagulation Viia Forecasted Revenue By Type (2023-2028)
6.2.3 Global Recombinant Human Coagulation Viia Revenue Market Share By Type (2017-2028)
6.3 Global Recombinant Human Coagulation Viia Price By Type
6.3.1 Global Recombinant Human Coagulation Viia Price By Type (2017-2022)
6.3.2 Global Recombinant Human Coagulation Viia Price Forecast By Type (2023-2028)
7 Market Size By Application
7.1 Global Recombinant Human Coagulation Viia Sales By Application
7.1.1 Global Recombinant Human Coagulation Viia Historical Sales By Application (2017-2022)
7.1.2 Global Recombinant Human Coagulation Viia Forecasted Sales By Application (2023-2028)
7.1.3 Global Recombinant Human Coagulation Viia Sales Market Share By Application (2017-2028)
7.2 Global Recombinant Human Coagulation Viia Revenue By Application
7.2.1 Global Recombinant Human Coagulation Viia Historical Revenue By Application (2017-2022)
7.2.2 Global Recombinant Human Coagulation Viia Forecasted Revenue By Application (2023-2028)
7.2.3 Global Recombinant Human Coagulation Viia Revenue Market Share By Application (2017-2028)
7.3 Global Recombinant Human Coagulation Viia Price By Application
7.3.1 Global Recombinant Human Coagulation Viia Price By Application (2017-2022)
7.3.2 Global Recombinant Human Coagulation Viia Price Forecast By Application (2023-2028)
8 Upstream Raw Materials And Downstream Analysis
8.1 Recombinant Human Coagulation Viia Industry Chain Analysis
8.2 Recombinant Human Coagulation Viia Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Recombinant Human Coagulation Viia Typical Customers
8.4 Recombinant Human Coagulation Viia Sales Channels
9 Recombinant Human Coagulation Viia Market Dynamics
9.1 Recombinant Human Coagulation Viia Industry Trends
9.2 Recombinant Human Coagulation Viia Market Drivers
9.3 Recombinant Human Coagulation Viia Market Challenges
9.4 Recombinant Human Coagulation Viia Market Restraints
10 Research Findings And Conclusion
11 Methodology And Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown And Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List Of Tables
Table 1. Global Recombinant Human Coagulation Viia Market Size Growth Rate By Type (Us$ Million): 2017 Vs 2021 Vs 2028
Table 2. Global Recombinant Human Coagulation Viia Market Size Growth By Application (Us$ Million): 2017 Vs 2021 Vs 2028
Table 3. Recombinant Human Coagulation Viia Industry Status
Table 4. Recombinant Human Coagulation Viia Industry Trends
Table 5. Global Recombinant Human Coagulation Viia Production By Region (K Units): 2021 Vs 2028
Table 6. Global Recombinant Human Coagulation Viia Production By Region (2017-2022) & (K Units)
Table 7. Global Recombinant Human Coagulation Viia Production Market Share By Region (2017-2022)
Table 8. Global Recombinant Human Coagulation Viia Production Forecast By Region (2023-2028) & (K Units)
Table 9. Global Recombinant Human Coagulation Viia Sales By Manufacturers (2017-2022) & (K Units)
Table 10. Global Recombinant Human Coagulation Viia Sales Share By Manufacturers (2017-2022)
Table 11. Global Recombinant Human Coagulation Viia Revenue By Manufacturers (2017-2022) & (Us$ Million)
Table 12. Global Recombinant Human Coagulation Viia Revenue Share By Manufacturers (2017-2022)
Table 13. Global Recombinant Human Coagulation Viia Manufacturers Ranking & (Based On The Revenue In Recombinant Human Coagulation Viia As Of 2021)
Table 14. Recombinant Human Coagulation Viia Price By Manufacturers 2017-2022 (Usd/Unit)
Table 15. China Recombinant Human Coagulation Viia Sales By Manufacturers (2017-2022) & (K Units)
Table 16. China Recombinant Human Coagulation Viia Sales Share By Manufacturers (2017-2022)
Table 17. China Recombinant Human Coagulation Viia Revenue By Manufacturers (2017-2022) & (Us$ Million)
Table 18. China Recombinant Human Coagulation Viia Revenue Share By Manufacturers (2017-2022)
Table 19. China Recombinant Human Coagulation Viia Manufacturers Ranking & (Based On The Revenue In Recombinant Human Coagulation Viia As Of 2021)
Table 20. Recombinant Human Coagulation Viia Price By Manufacturers 2017-2022 (Usd/Unit)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings